Inogen

Inogen OpEx/Revenue

The Operating Expenses to Revenue Ratio of Inogen (INGN) as of Nov 20, 2026 is 24.89 %. In the previous year, Operating Expenses to Revenue Ratio was 28.06 % — a change of -11.29% (lower).

OpEx/Revenue

24.89 %

YoY

-11.29%

Last updated:

Operating Expenses to Revenue Ratio of Inogen is 2025 24.89 % . Operating Expenses to Revenue Ratio of Inogen was 2024 28.06 % . It decreases by -11.29% lower compared to the previous year.

The Inogen OpEx/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OpEx/Revenue
Date
OpEx/Revenue
Jan 1, 2018
12.58 USD
Jan 1, 2019
12.85 USD
Jan 1, 2020
17.08 USD
Jan 1, 2021
15.20 USD
Jan 1, 2022
17.46 USD
Jan 1, 2023
30.44 USD
Jan 1, 2024
28.06 USD
Jan 1, 2025
24.89 USD
The Inogen OpEx/Revenue history
YEAROpEx/RevenueYoY
24.89 %-11.29%
28.06 %-7.84%
30.44 %+74.41%
17.46 %+14.81%
15.20 %-10.98%
17.08 %+32.87%
12.85 %+2.18%
12.58 %-26.84%
17.19 %-5.50%
18.20 %-3.04%
18.77 %+0.95%
18.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

Operating Expenses to Revenue Ratio of Inogen is 24.89 % in 2025.

Operating Expenses to Revenue Ratio of Inogen changed from 28.06 % to 24.89 %, representing a -11.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Expenses to Revenue Ratio Inogen since 2006 – with annual values, charts, and detailed analysis.

The OpEx/Revenue ratio measures total operating expenses as a percentage of revenue. Declining ratios suggest improving operational leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Expenses to Revenue Ratio's Inogen with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Expenses to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Expenses to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Inogen

All Key Metrics — Inogen